Regentis Biomaterials (RGNT) Invested Capital (2024 - 2025)

Regentis Biomaterials (RGNT) reported Invested Capital of $5.9 million for Q4 2025, up 116.17% year-over-year from $2.7 million in Q4 2024, and up 116.17% quarter-over-quarter from -$36.7 million in Q4 2024.

Regentis Biomaterials (RGNT) Invested Capital (2024 - 2025) Analysis & Trends

Regentis Biomaterials (RGNT) has 2 years of Invested Capital data on file, last reported at $5.9 million in Q4 2025.

  • Invested Capital for Q4 2025 came in at $5.9 million, up 116.17% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.9 million (up 116.17% YoY), and the FY2025 annual result was $5.9 million, up 116.17% from the prior year.
  • Invested Capital advanced to $5.9 million in Q4 2025 per RGNT's latest filing, from -$36.7 million in the prior quarter.
  • Over five years, Invested Capital peaked at $5.9 million in Q4 2025 and troughed at -$36.7 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 17.60 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 26.71 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 11.35 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 6.90 Bn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 3.19 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 5.18 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 8.84 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 4.15 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 6.86 Bn
10 Regentis Biomaterials 3.72 Mn -3.66 Mn - 5.94 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.94 Mn
Dec 31, 2024 -36.73 Mn